(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 6.6% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Qiagen Nv's revenue in 2026 is $2,089,999,000.On average, 25 Wall Street analysts forecast QGEN's revenue for 2026 to be $490,457,781,835, with the lowest QGEN revenue forecast at $468,765,708,335, and the highest QGEN revenue forecast at $509,763,727,250. On average, 24 Wall Street analysts forecast QGEN's revenue for 2027 to be $518,440,556,650, with the lowest QGEN revenue forecast at $483,950,159,785, and the highest QGEN revenue forecast at $546,423,331,465.
In 2028, QGEN is forecast to generate $549,894,063,225 in revenue, with the lowest revenue forecast at $510,631,410,190 and the highest revenue forecast at $582,649,094,210.